Is APOE useful for fatigue?

The utility of the APOE genotype for understanding fatigue is limited and not clinically established. APOE (apolipoprotein E) is primarily studied for its role in lipid metabolism and Alzheimer's disease risk. Some research suggests that APOE ε4 carriers may experience higher levels of cognitive fatigue or reduced energy, especially in aging populations or those with mild cognitive impairment. However, these findings are exploratory and not robust enough for individual clinical recommendations. Fatigue is a complex, multifactorial symptom with causes ranging from sleep deprivation, nutritional deficiencies (e.g., iron, B12), thyroid dysfunction, mental health issues, to chronic inflammatory conditions. A single genetic variant like APOE ε4 has very low predictive power for general fatigue in the population. Direct-to-consumer DNA tests that include APOE often market it for brain health or longevity, but they lack clinical validation for fatigue management. The evidence level is 'mixed': there are mechanistic and observational hints, but no strong interventional trials. Therefore, relying on APOE for fatigue guidance is not evidence-based. A comprehensive medical workup is essential.